Search

Your search keyword '"Perrin, Lewis"' showing total 255 results
Start Over Author "Perrin, Lewis"
255 results on '"Perrin, Lewis"'

2. Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer

Author

Bonazzi, Vanessa F., Kondrashova, Olga, Smith, Deborah, Nones, Katia, Sengal, Asmerom T., Ju, Robert, Packer, Leisl M., Koufariotis, Lambros T., Kazakoff, Stephen H., Davidson, Aimee L., Ramarao-Milne, Priya, Lakis, Vanessa, Newell, Felicity, Rogers, Rebecca, Davies, Claire, Nicklin, James, Garrett, Andrea, Chetty, Naven, Perrin, Lewis, Pearson, John V., Patch, Ann-Marie, Waddell, Nicola, and Pollock, Pamela M.

Published
2022
Full Text
View/download PDF

3. Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial

Author

Janda, Monika, Robledo, Kristy P., Gebski, Val, Armes, Jane E., Alizart, Michelle, Cummings, Margaret, Chen, Chen, Leung, Yee, Sykes, Peter, McNally, Orla, Oehler, Martin K., Walker, Graeme, Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James L., Chetty, Naven, Perrin, Lewis C., Hoet, Greet, Sowden, Katherine, Eva, Lois, Tristram, Amanda, and Obermair, Andreas

Published
2021
Full Text
View/download PDF

6. Establishing the sensitivity and specificity of the gynaecological cancer distress screen.

Author

Seib, Charrlotte, Harbeck, Emma, Anderson, Debra, Porter‐Steele, Janine, Nehill, Caroline, Sanmugarajah, Jasotha, Perrin, Lewis, Shannon, Catherine, Cabraal, Nimithri, Jennings, Bronwyn, Otton, Geoffrey, Adams, Catherine, Mellon, Anne, and Chambers, Suzanne

Subjects
GYNECOLOGIC cancer, PSYCHOLOGICAL distress, EARLY detection of cancer, SENSITIVITY & specificity (Statistics), RECEIVER operating characteristic curves
Abstract

Objective: Nuanced distress screening tools can help cancer care services manage specific cancer groups' concerns more efficiently. This study examines the sensitivity and specificity of a tool specifically for women with gynaecological cancers (called the Gynaecological Cancer Distress Screen or DT‐Gyn). Methods: This paper presents cross‐sectional data from individuals recently treated for gynaecological cancer recruited through Australian cancer care services, partner organisations, and support/advocacy services. Receiver operating characteristics analyses were used to evaluate the diagnostic accuracy of the DT‐Gyn against criterion measures for anxiety (GAD‐7), depression (patient health questionnaire), and distress (IES‐R and K10). Results: Overall, 373 individuals aged 19–91 provided complete data for the study. Using the recognised distress thermometer (DT) cut‐off of 4, 47% of participants were classified as distressed, while a cut‐off of 5 suggested that 40% had clinically relevant distress. The DT‐Gyn showed good discriminant ability across all measures (IES‐R: area under the curve (AUC) = 0.86, 95% CI = 0.82–0.90; GAD‐7: AUC = 0.89, 95% CI = 0.85–0.93; K10: AUC = 0.88, 95% CI = 0.85–0.92; PHQ‐9: AUC = 0.85, 95% CI = 0.81–0.89) and the Youden Index suggested an optimum DT cut‐point of 5. Conclusions: This study established the psychometric properties of the DT‐Gyn, a tool designed to identify and manage the common sources of distress in women with gynaecological cancers. We suggest a DT cut point ≥5 is optimal in detecting 'clinically relevant' distress, anxiety, and depression in this population. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

7. Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high‐grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context

Author

Samoylovich, Arthur, primary, Jennings, Bronwyn, additional, Shannon, Catherine, additional, Coward, Jermaine I., additional, Lourie, Rohan, additional, Riordan, John, additional, Lai, Nai An, additional, van Driel, Willemien J., additional, Cabraal, Nimithri, additional, Jagasia, Nisha, additional, Chetty, Naven, additional, Naidu, Sanjeev, additional, Perrin, Lewis C., additional, and Barry, Sinead C., additional

Published
2023
Full Text
View/download PDF

11. Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition.

Author

Sengal, Asmerom, primary, Bonazzi, Vanessa, additional, Smith, Deborah, additional, Moiola, Cristian, additional, Lourie, Rohan, additional, Rogers, Rebecca, additional, Colas, Eva, additional, Gil-Moreno, Antonio, additional, Frentzas, Sophia, additional, Chetty, Naven, additional, Perrin, Lewis, additional, and Pollock, Pamela, additional

Published
2023
Full Text
View/download PDF

16. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial

Author

Janda, Monika, Gebski, Val, Davies, Lucy C., Forder, Peta, Brand, Alison, Hogg, Russell, Jobling, Thomas W., Land, Russell, Manolitsas, Tom, Nascimento, Marcelo, Neesham, Deborah, Nicklin, James L., Oehler, Martin K., Otton, Geoff, Perrin, Lewis, Salfinger, Stuart, Hammond, Ian, Leung, Yee, Sykes, Peter, Ngan, Hextan, Garrett, Andrea, Laney, Michael, Ng, Tong Yow, Tam, Karfai, Chan, Karen, Wrede, C. David, Pather, Selvan, Simcock, Bryony, Farrell, Rhonda, Robertson, Gregory, Walker, Graeme, Armfield, Nigel R., Graves, Nick, McCartney, Anthony J., and Obermair, Andreas

Published
2017
Full Text
View/download PDF

17. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial

Author

Kondalsamy-Chennakesavan, Srinivas, Janda, Monika, Gebski, Val, Baker, Jannah, Brand, Alison, Hogg, Russell, Jobling, Thomas W., Land, Russell, Manolitsas, Tom, Nascimento, Marcelo, Neesham, Deborah, Nicklin, James L., Oehler, Martin K., Otton, Geoff, Perrin, Lewis, Salfinger, Stuart, Hammond, Ian, Leung, Yee, Sykes, Peter, Ngan, Hextan, Garrett, Andrea, Laney, Michael, Ng, Tong Yow, Tam, Karfai, Chan, Karen, Wrede, David H., Pather, Selvan, Simcock, Bryony, Farrell, Rhonda, Robertson, Gregory, Walker, Graeme, McCartney, Anthony, and Obermair, Andreas

Published
2012
Full Text
View/download PDF

19. Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial

Author

Obermair, Andreas, Janda, Monika, Baker, Jannah, Kondalsamy-Chennakesavan, Srinivas, Brand, Alison, Hogg, Russell, Jobling, Thomas W., Land, Russell, Manolitsas, Tom, Nascimento, Marcelo, Neesham, Deborah, Nicklin, James L., Oehler, Martin K., Otton, Geoff, Perrin, Lewis, Salfinger, Stuart, Hammond, Ian, Leung, Yee, Sykes, Peter, Ngan, Hextan, Garrett, Andrea, Laney, Michael, Ng, Tong Yow, Tam, Karfai, Chan, Karen, Wrede, David H., Pather, Selvan, Simcock, Bryony, Farrell, Rhonda, Robertson, Gregory, Walker, Graeme, McCartney, Anthony, and Gebski, Val

Published
2012
Full Text
View/download PDF

20. Additional file 1 of Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer

Author

Bonazzi, Vanessa F., Kondrashova, Olga, Smith, Deborah, Nones, Katia, Sengal, Asmerom T., Ju, Robert, Packer, Leisl M., Koufariotis, Lambros T., Kazakoff, Stephen H., Davidson, Aimee L., Ramarao-Milne, Priya, Lakis, Vanessa, Newell, Felicity, Rogers, Rebecca, Davies, Claire, Nicklin, James, Garrett, Andrea, Chetty, Naven, Perrin, Lewis, Pearson, John V., Patch, Ann-Marie, Waddell, Nicola, and Pollock, Pamela M.

Abstract

Additional file 1: Supplementary Methods, Supplementary Tables 1-3,5 and Supplementary Figures.

Published
2022
Full Text
View/download PDF

25. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial

Author

Janda, Monika, Gebski, Val, Brand, Alison, Hogg, Russel, Jobling, Thomas W, Land, Russel, Manolitsas, Tom, McCartney, Anthony, Nascimento, Marcelo, Neesham, Deborah, Nicklin, James L, Oehler, Martin K, Otton, Geoff, Perrin, Lewis, Salfinger, Stuart, Hammond, Ian, Leung, Yee, Walsh, Tom, Sykes, Peter, Ngan, Hextan, Garrett, Andrea, Laney, Michael, Ng, Tong Yow, Tam, Karfai, Chan, Karen, Wrede, C David H, Pather, Selvan, Simcock, Bryony, Farrell, Rhonda, and Obermair, Andreas

Published
2010
Full Text
View/download PDF

26. Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer

Author

He, Yaowu, primary, Khan, Tashbib, additional, Kryza, Thomas, additional, Jones, Martina L., additional, Goh, Justin B., additional, Lyons, Nicholas J., additional, Pearce, Lesley A., additional, Lee, Michael D, additional, Gough, Madeline, additional, Rogers, Rebecca, additional, Davies, Claire M, additional, Gilks, C. Blake, additional, Hodgkinson, Thomas, additional, Lourie, Rohan, additional, Barry, Sinead C., additional, Perrin, Lewis C., additional, Williams, Charlotte C., additional, Puttick, Simon, additional, Adams, Timothy E., additional, Munro, Trent P., additional, Hooper, John D., additional, and Chetty, Naven, additional

Published
2021
Full Text
View/download PDF

27. Complete pathological response following levonorgestrel intrauterine device in clinically stage I endometrial adenocarcinoma: Results of a randomized clinical trial

Author

Janda, Monika, primary, Robledo, Kristy, additional, Gebski, Val, additional, Armes, Jane, additional, Alizart, Michelle, additional, Cummings, Margaret, additional, Chen, Chen, additional, Leung, Yee, additional, Sykes, Peter, additional, McNally, Orla, additional, Oehler, Martin, additional, Garrett, Andrea, additional, Tang, Amy, additional, Nicklin, James, additional, Chetty, Naven, additional, Perrin, Lewis, additional, Sowden, Katherine, additional, Eva, Lois, additional, Tristram, Amanda, additional, and Obermair, Andreas, additional

Published
2021
Full Text
View/download PDF

29. Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence

Author

Alharbi, Mona, primary, Lai, Andrew, additional, Sharma, Shayna, additional, Kalita-de Croft, Priyakshi, additional, Godbole, Nihar, additional, Campos, America, additional, Guanzon, Dominic, additional, Salas-Burgos, Alexis, additional, Carrion, Flavio, additional, Zuñiga, Felipe A., additional, Perrin, Lewis, additional, He, Yaowu, additional, Pejovic, Tanja, additional, Winters, Carmen, additional, Morgan, Terry, additional, Hooper, John D., additional, Rice, Gregory E., additional, and Salomon, Carlos, additional

Published
2021
Full Text
View/download PDF

31. Genomic analysis of patient-derived xenograft models reveals intra-tumor heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib

Author

Bonazzi, Vanessa F., primary, Kondrashova, Olga, additional, Smith, Deborah, additional, Nones, Katia, additional, Sengal, Asmerom T., additional, Ju, Robert, additional, Packer, Leisl M., additional, Koufariotis, Lambros T., additional, Kazakoff, Stephen H., additional, Davidson, Aimee L., additional, Ramarao-Milne, Priya, additional, Lakis, Vanessa, additional, Newell, Felicity, additional, Rogers, Rebecca, additional, Davies, Claire, additional, Nicklin, James, additional, Garrett, Andrea, additional, Chetty, Naven, additional, Perrin, Lewis, additional, Pearson, John V., additional, Patch, Ann-Marie, additional, Waddell, Nicola, additional, and Pollock, Pamela, additional

Published
2021
Full Text
View/download PDF

32. Abstract PR007: Genomic characterization of endometrial cancer patient-derived xenografts reveals intratumor heterogeneity

Author

Kondrashova, Olga, primary, Bonazzi, Vanessa F., additional, Smith, Deborah, additional, Nones, Katia, additional, Sengal, Asmerom, additional, Ju, Robert, additional, Packer, Leisl M., additional, Koufariotis, Lambros T, additional, Kazakoff, Stephen H., additional, Davidson, Aimee L., additional, Ramarao-Milne, Priya, additional, Lakis, Vanessa, additional, Newell, Felicity, additional, Rogers, Rebecca, additional, Davies, Claire, additional, Chetty, Naven, additional, Perrin, Lewis, additional, Pearson, John, additional, Patch, Ann-Marie, additional, Garrett, Andrea, additional, Waddell, Nicola, additional, Pollock, Pamela, additional, and Nicklin, James, additional

Published
2021
Full Text
View/download PDF

33. Disruption of glycogen utilization markedly improves the efficacy of carboplatin against preclinical models of clear cell ovarian carcinoma

Author

Khan, Tashbib, He, Yaowu, Kryza, Thomas, Harrington, Brittney S., Gunter, Jennifer, Sullivan, Mitchell A., Cuda, Tahleesa, Rogers, Rebecca, Davies, Claire M., Broomfield, Amy, Gough, Madeline, Wu, Andy C, McGann, Thomas, Weroha, S. John, Haluska, Paul, Forbes, Josephine, Armes, Jane E., Barry, Sinead C., Coward, Jermaine I., Jagasia, Nisha, Chetty, Naven, Snell, Cameron E., Lourie, Rohan, Perrin, Lewis C., Hooper, John, Khan, Tashbib, He, Yaowu, Kryza, Thomas, Harrington, Brittney S., Gunter, Jennifer, Sullivan, Mitchell A., Cuda, Tahleesa, Rogers, Rebecca, Davies, Claire M., Broomfield, Amy, Gough, Madeline, Wu, Andy C, McGann, Thomas, Weroha, S. John, Haluska, Paul, Forbes, Josephine, Armes, Jane E., Barry, Sinead C., Coward, Jermaine I., Jagasia, Nisha, Chetty, Naven, Snell, Cameron E., Lourie, Rohan, Perrin, Lewis C., and Hooper, John

Abstract

High stage and recurrent ovarian clear cell carcinoma (OCC) are associated with poor prognosis and resistance to chemotherapy. A distinguishing histological feature of OCC is abundant cytoplasmic stores of glucose, in the form of glycogen, that can be mobilized for cellular metabolism. Here, we report the effect on preclinical models of OCC of disrupting glycogen utilization using the glucose analogue 2-deoxy-D-glucose (2DG). At concentrations significantly lower than previously reported for other cancers, 2DG markedly improves the efficacy in vitro of carboplatin chemotherapy against chemo-sensitive TOV21G and chemo-resistant OVTOKO OCC cell lines, and this is accompanied by the depletion of glycogen. Of note, 2DG doses—of more than 10-fold lower than previously reported for other cancers—significantly improve the efficacy of carboplatin against cell line and patient-derived xenograft models in mice that mimic the chemo-responsiveness of OCC. These findings are encouraging, in that 2DG doses, which are substantially lower than previously reported to cause adverse events in cancer patients, can safely and significantly improve the efficacy of carboplatin against OCC. Our results thus justify clinical trials to evaluate whether low dose 2DG improves the efficacy of carboplatin in OCC patients.

Published
2020

34. Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

Author

Harrington, Brittney S., He, Yaowu, Khan, Tashbib, Puttick, Simon, Conroy, Paul J., Kryza, Thomas, Cuda, Tahleesa, Sokolowski, Kamil A., Tse, Brian W.C., Robbins, Katherine K., Arachchige, Buddhika J., Stehbens, Samantha J., Pollock, Pamela M., Reed, Sarah, Weroha, S. John, Haluska, Paul, Salomon, Carlos, Lourie, Rohan, Perrin, Lewis C., Law, Ruby H.P., Whisstock, James C., Hooper, John D., Harrington, Brittney S., He, Yaowu, Khan, Tashbib, Puttick, Simon, Conroy, Paul J., Kryza, Thomas, Cuda, Tahleesa, Sokolowski, Kamil A., Tse, Brian W.C., Robbins, Katherine K., Arachchige, Buddhika J., Stehbens, Samantha J., Pollock, Pamela M., Reed, Sarah, Weroha, S. John, Haluska, Paul, Salomon, Carlos, Lourie, Rohan, Perrin, Lewis C., Law, Ruby H.P., Whisstock, James C., and Hooper, John D.

Abstract

CUB-domain containing protein 1 (CDCP1) is a cancer associated cell surface protein that amplifies pro-tumorigenic signalling by other receptors including EGFR and HER2. Its potential as a cancer target is supported by studies showing that anti-CDCP1 antibodies inhibit cell migration and survival in vitro, and tumor growth and metastasis in vivo. Here we characterize two anti-CDCP1 antibodies, focusing on immuno-conjugates of one of these as a tool to detect and inhibit ovarian cancer.Methods: A panel of ovarian cancer cell lines was examined for cell surface expression of CDCP1 and loss of expression induced by anti-CDCP1 antibodies 10D7 and 41-2 using flow cytometry and Western blot analysis. Surface plasmon resonance analysis and examination of truncation mutants was used to analyse the binding properties of the antibodies for CDCP1. Live-cell spinning-disk confocal microscopy of GFP-tagged CDCP1 was used to track internalization and intracellular trafficking of CDCP1/antibody complexes. In vivo, zirconium 89-labelled 10D7 was detected by positron-emission tomography imaging, of an ovarian cancer patient-derived xenograft grown intraperitoneally in mice. The efficacy of cytotoxin-conjugated 10D7 was examined against ovarian cancer cells in vitro and in vivo.Results: Our data indicate that each antibody binds with high affinity to the extracellular domain of CDCP1 causing rapid internalization of the receptor/antibody complex and degradation of CDCP1 via processes mediated by the kinase Src. Highlighting the potential clinical utility of CDCP1, positron-emission tomography imaging, using zirconium 89-labelled 10D7, was able to detect subcutaneous and intraperitoneal xenograft ovarian cancers in mice, including small (diameter <3 mm) tumor deposits of an ovarian cancer patient-derived xenograft grown intraperitoneally in mice. Furthermore, cytotoxin-conjugated 10D7 was effective at inhibiting growth of CDCP1-expressing ovarian cancer cells in vitro and in vivo.Conc

Published
2020

37. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer

Author

Yao, Shih-Ern, primary, Tripcony, Lee, additional, Sanday, Karen, additional, Robertson, Jessica, additional, Perrin, Lewis, additional, Chetty, Naven, additional, Land, Russell, additional, Garrett, Andrea, additional, Obermair, Andreas, additional, Nascimento, Marcelo, additional, Tang, Amy, additional, Jagasia, Nisha, additional, Singh, Piksi, additional, and Nicklin, Jim, additional

Published
2020
Full Text
View/download PDF

39. Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma

Author

Khan, Tashbib, primary, He, Yaowu, additional, Kryza, Thomas, additional, Harrington, Brittney S., additional, Gunter, Jennifer H., additional, Sullivan, Mitchell A., additional, Cuda, Tahleesa, additional, Rogers, Rebecca, additional, Davies, Claire M., additional, Broomfield, Amy, additional, Gough, Madeline, additional, Wu, Andy C., additional, McGann, Thomas, additional, Weroha, S. John, additional, Haluska, Paul, additional, Forbes, Josephine M., additional, Armes, Jane E., additional, Barry, Sinead C., additional, Coward, Jermaine I., additional, Jagasia, Nisha, additional, Chetty, Naven, additional, Snell, Cameron E., additional, Lourie, Rohan, additional, Perrin, Lewis C., additional, and Hooper, John D., additional

Published
2020
Full Text
View/download PDF

40. Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

Author

Harrington, Brittney S., primary, He, Yaowu, additional, Khan, Tashbib, additional, Puttick, Simon, additional, Conroy, Paul J., additional, Kryza, Thomas, additional, Cuda, Tahleesa, additional, Sokolowski, Kamil A, additional, Tse, Brian WC, additional, Robbins, Katherine K., additional, Arachchige, Buddhika J., additional, Stehbens, Samantha J., additional, Pollock, Pamela M., additional, Reed, Sarah, additional, Weroha, S. John, additional, Haluska, Paul, additional, Salomon, Carlos, additional, Lourie, Rohan, additional, Perrin, Lewis C., additional, Law, Ruby H. P., additional, Whisstock, James C., additional, and Hooper, John D, additional

Published
2020
Full Text
View/download PDF

49. Comparison between laparoscopic and robotic surgery for sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging.

Author

Chaowawanit, Woraphot, Campbell, Vicki, Wilson, Emily, Chetty, Naven, Perrin, Lewis, Jagasia, Nisha, and Barry, Sinead

Subjects
LYMPH node surgery, ENDOMETRIAL surgery, SURGICAL robots, SENTINEL lymph nodes, INFRARED imaging, LAPAROSCOPIC surgery
Abstract

Indocyanine green (ICG) and near infra-red fluorescence imaging in minimally invasive surgery is an option to map sentinel lymph nodes (SLN). The aim of this study was to compare the outcomes of SLN mapping between laparoscopic and robotic surgery. One-hundred-and-forty women with histologically confirmed endometrial cancer, were treated with a minimally invasive hysterectomy, bilateral salpingo-oophorectomy and SLN mapping. After anaesthetic induction, ICG was superficially injected into cervical submucosa and deeply injected into the cervical stroma at the 3 and 9 o'clock positions (1.25 mg/site). Eleven cases were abandoned after ICG injection (laparoscopic surgery seven cases and robotic surgery four cases) because of obesity, technical difficulty and peritoneal disease. One-hundred-and-eleven patients were analysed. Seventy-six patients had a laparoscopic procedure and 33 patients had robotic surgery. The overall and bilateral detection rates were 97% and 83% for laparoscopic surgery and 88% and 73% for robotic surgery. Laparoscopic surgery was superior to robotic surgery in terms of overall detection (p-value.046). There was no significant difference in the intra-operative SLN identification time or SLN dissection time between laparoscopy and robotic surgery (p-value.247 and.145, respectively). Further research is required to compare laparoscopy and robotic surgery in terms of SLN detection. What is already known on this subject? Sentinel lymph node (SLN) mapping aims to avoid complications and provide useful staging information for endometrial cancer. ICG has been shown to improve the detection rate and NPV compared with other tracers (blue dye and technetium 99). No data exists comparing SLN mapping rates using ICG in laparoscopy and robotic surgery. What do the results of this study add? The overall and bilateral detection rates were 97% and 83% for laparoscopic surgery and 88% and 73% for robotic surgery. Laparoscopic surgery was superior to robotic surgery in terms of overall detection. There was no significant difference in the intra-operative SLN identification time or SLN dissection time between laparoscopy and robotic surgery. What are the implications of these findings for clinical practice and/or further research?: This study confirms that laparoscopy and robotic surgery are not different in terms of bilateral detection rate and SLN operating time; the study population is small. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results